Sign In
Buy BBH
$181.73
-4.21 (-2.26%)
At Close: Jun 02, 2026
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 30'th Jun 2025
Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
BBH: Fear Of Price Controls Is Not The Problem
09:00am, Wednesday, 14'th May 2025
The executive order aims to reduce drug prices by allowing direct sales to consumers and cutting out PBMs but faces significant challenges. The main risk for biotech is FDA approval delays due to skep
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Tuesday, 29'th Apr 2025
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Tuesday, 25'th Feb 2025
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Tuesday, 24'th Dec 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
08:56pm, Friday, 20'th Dec 2024
NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 22'nd Oct 2024
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 19'th Aug 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
BBH: Buy Rating, As Tech Investors Look Beyond FAANG
05:12am, Tuesday, 23'rd Jul 2024
Biotechnology sector experiencing exponential growth driven by emerging technologies addressing global challenges. VanEck Biotech ETF tracks top U.S.-listed biotech companies, offers exposure to innov
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024
06:00am, Wednesday, 26'th Jun 2024
I'm on the hunt for ‘Strong Buy' biotech stocks. According to Finviz.com, there are 680 U.S.-listed biotech stocks.
Biotech ETF (BBH) Hits New 52-Week High
08:00am, Tuesday, 25'th Jun 2024
VanEck Biotech ETF BBH is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 21.4% from its 52-week low price of $142.51/share.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Monday, 17'th Jun 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
BOSTON--(BUSINESS WIRE)--As the ETF industry reaches a milestone of $12.71 trillion in global assets, the Brown Brothers Harriman 2024 Global ETF Investor Survey finds that investors plan to further i
Should You Invest in the VanEck Biotech ETF (BBH)?
07:20am, Monday, 15'th Apr 2024
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
Why Biotech Stocks May Be Ready For A Recovery
03:59am, Saturday, 09'th Mar 2024
Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stoc
